kinase inhibitor

You have access
The Suppressive Effect of Rebastinib on Triple-negative Breast Cancer Tumors Involves Multiple Mechanisms of Action
KUNXIAN FENG, CHENGFANG JIAN, HAIHUA XIAO, HUANGYU JIANG, JINPING YANG, MENGLI YANG, ANDRE SUN, WENMING SONG, ALEXANDER V. CHESTKOV, NATALYA I. VASILEVICH and LICHUN SUN

Anticancer Research June 2023, 43 (6) 2609-2624; DOI: https://doi.org/10.21873/anticanres.16428
You have access
Prognosis of Patients With Interstitial Lung Disease Induced by Different Pharmacological Types of Anticancer Drugs
KOHEI IWASHITA, TOMOHIRO MIZUNO, SATOMI KUMAZAWA, KAZUYOSHI IMAIZUMI and SHIGEKI YAMADA

Anticancer Research May 2021, 41 (5) 2563-2568; DOI: https://doi.org/10.21873/anticanres.15034
You have access
Interactive Analysis of TX-1123 with Cyclo-oxygenase: Design of COX2 Selective TX Analogs
KAZUTO OHKURA, YOHEI TATEMATSU, YUKI KAWAGUCHI, YOSHIHIRO UTO and HITOSHI HORI

Anticancer Research July 2017, 37 (7) 3849-3854;
You have access
An Antitumor 2-Hydroxyarylidene-4-cyclopentene-1,3-Dione as a Protein Tyrosine Kinase Inhibitor: Interaction Between TX-1123 Derivatives and Src Kinase
KAZUTO OHKURA, YUKI KAWAGUCHI, YOHEI TATEMATSU, YOSHIHIRO UTO and HITOSHI HORI

Anticancer Research July 2016, 36 (7) 3645-3649;
You have access
Specific RSK Kinase Inhibition by Dibenzyl Trisulfide and Implication for Therapeutic Treatment of Cancer
HENRY I.C. LOWE, CAROLINE O.B. FACEY, NGEH J. TOYANG and JOSEPH L. BRYANT

Anticancer Research April 2014, 34 (4) 1637-1641;

Main menu